A clinical study of Tiotropium/Olodaterol Vs Fluticasone Furoate/Umeclidinium/Vilanterol in patients with Chronic Obstructive Pulmonary Disease
Latest Information Update: 22 Jul 2022
At a glance
- Drugs Fluticasone furoate/umeclidinium/vilanterol (Primary) ; Olodaterol/tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
Most Recent Events
- 22 Jul 2022 New trial record